0001567619-19-010747.txt : 20190514 0001567619-19-010747.hdr.sgml : 20190514 20190514121726 ACCESSION NUMBER: 0001567619-19-010747 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190514 EFFECTIVENESS DATE: 20190514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EFFECTOR THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001577561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455286092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339536 FILM NUMBER: 19821504 BUSINESS ADDRESS: STREET 1: 11180 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-925-8215 MAIL ADDRESS: STREET 1: 11180 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001577561 EFFECTOR THERAPEUTICS, INC. 11180 Roselle Street SAN DIEGO CA CALIFORNIA 92121 (858) 925-8215 DELAWARE None None Corporation true Stephen T. Worland, Ph.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Executive Officer Director Laurence Lasky, Ph.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director Simeon J. George, M.D. c/o eFFECTOR Therapeutics, Inc 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director Kenneth Haas, J.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director Jonathan D. Root, M.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director David Maki, J.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director Alana McNulty c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Executive Officer Stefan Larson, Ph.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director John W. Smither c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director Denis Patrick, Ph.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle Street San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2019-04-30 false true false 0 21800011 20422514 1377497 For Series C, Preferred Stock. false 25 0 0 0 false EFFECTOR THERAPEUTICS, INC. /s/ Stephen T. Worland, Ph.D. Stephen T. Worland, Ph.D. President and Chief Executive Officer 2019-05-13